Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia

Christopher Stasik; Siddhartha Ganguly; Mark T. Cunningham; Stacey Hagemeister; Diane L. Persons

doi:10.1016/j.cancergencyto.2006.02.013

Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia

Christopher Stasik, Siddhartha Ganguly, Mark T. Cunningham, Stacey Hagemeister, Diane L. Persons

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Rearrangements of the mixed-lineage leukemia (MLL) gene have been associated with a poor prognosis in infant acute lymphoblastic leukemia (ALL). Previously, MLL translocations involving the CREP-binding protein (CREBBP) gene at chromosome band 16p13.3 have primarily been reported in treatment-related acute myeloid leukemia, after chemotherapy for other primary malignancies using topoisomerase II inhibitors. We report a case of de novo infant ALL with t(11;16)(q23;p13.3). After chemotherapy, this patient developed an acute monoblastic leukemia (M5b) with retention of the t(11;16)(q23;p13.3), indicating that this is a lineage switch of the original leukemic clone. To our knowledge, these findings have not been previously reported.

Original language	English (US)
Pages (from-to)	146-149
Number of pages	4
Journal	Cancer Genetics and Cytogenetics
Volume	168
Issue number	2
DOIs	https://doi.org/10.1016/j.cancergencyto.2006.02.013
State	Published - Jul 15 2006

ASJC Scopus subject areas

Molecular Biology
Genetics
Cancer Research

Access to Document

10.1016/j.cancergencyto.2006.02.013

Cite this

@article{ca9799466f5c43299a9cadad382611e9,

title = "Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia",

abstract = "Rearrangements of the mixed-lineage leukemia (MLL) gene have been associated with a poor prognosis in infant acute lymphoblastic leukemia (ALL). Previously, MLL translocations involving the CREP-binding protein (CREBBP) gene at chromosome band 16p13.3 have primarily been reported in treatment-related acute myeloid leukemia, after chemotherapy for other primary malignancies using topoisomerase II inhibitors. We report a case of de novo infant ALL with t(11;16)(q23;p13.3). After chemotherapy, this patient developed an acute monoblastic leukemia (M5b) with retention of the t(11;16)(q23;p13.3), indicating that this is a lineage switch of the original leukemic clone. To our knowledge, these findings have not been previously reported.",

author = "Christopher Stasik and Siddhartha Ganguly and Cunningham, {Mark T.} and Stacey Hagemeister and Persons, {Diane L.}",

year = "2006",

month = jul,

day = "15",

doi = "10.1016/j.cancergencyto.2006.02.013",

language = "English (US)",

volume = "168",

pages = "146--149",

journal = "Cancer Genetics and Cytogenetics",

issn = "0165-4608",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia

AU - Stasik, Christopher

AU - Ganguly, Siddhartha

AU - Cunningham, Mark T.

AU - Hagemeister, Stacey

AU - Persons, Diane L.

PY - 2006/7/15

Y1 - 2006/7/15

N2 - Rearrangements of the mixed-lineage leukemia (MLL) gene have been associated with a poor prognosis in infant acute lymphoblastic leukemia (ALL). Previously, MLL translocations involving the CREP-binding protein (CREBBP) gene at chromosome band 16p13.3 have primarily been reported in treatment-related acute myeloid leukemia, after chemotherapy for other primary malignancies using topoisomerase II inhibitors. We report a case of de novo infant ALL with t(11;16)(q23;p13.3). After chemotherapy, this patient developed an acute monoblastic leukemia (M5b) with retention of the t(11;16)(q23;p13.3), indicating that this is a lineage switch of the original leukemic clone. To our knowledge, these findings have not been previously reported.

AB - Rearrangements of the mixed-lineage leukemia (MLL) gene have been associated with a poor prognosis in infant acute lymphoblastic leukemia (ALL). Previously, MLL translocations involving the CREP-binding protein (CREBBP) gene at chromosome band 16p13.3 have primarily been reported in treatment-related acute myeloid leukemia, after chemotherapy for other primary malignancies using topoisomerase II inhibitors. We report a case of de novo infant ALL with t(11;16)(q23;p13.3). After chemotherapy, this patient developed an acute monoblastic leukemia (M5b) with retention of the t(11;16)(q23;p13.3), indicating that this is a lineage switch of the original leukemic clone. To our knowledge, these findings have not been previously reported.

UR - http://www.scopus.com/inward/record.url?scp=33745683767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745683767&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2006.02.013

DO - 10.1016/j.cancergencyto.2006.02.013

M3 - Article

C2 - 16843104

AN - SCOPUS:33745683767

SN - 0165-4608

VL - 168

SP - 146

EP - 149

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

IS - 2

ER -

Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this